pyrroles has been researched along with Macular Edema in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauermann, P; Heiligenhaus, A; Heinz, C | 1 |
| Coutinho, FP; Ramtin, A; Rupenthal, ID; Seyfoddin, A; Svirskis, D; Waterhouse, GI | 1 |
| Erginay, A; Gaudric, A; Girmens, JF; Massin, P; Richard, S; Scigalla, P | 1 |
| Bhansali, A; Gupta, A; Gupta, V; Thapar, S | 1 |
| Kitano, S | 1 |
| Dolan, BJ; Flach, AJ; Irvine, AR | 1 |
1 review(s) available for pyrroles and Macular Edema
| Article | Year |
|---|---|
[Medications for diabetic macular edema].
Topics: Acetazolamide; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; Humans; Indoles; Injections, Intralesional; Macular Edema; Maleimides; Prognosis; Protein Kinase C; Protein Kinase C beta; Pyrroles; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2005 |
2 trial(s) available for pyrroles and Macular Edema
| Article | Year |
|---|---|
Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema.
Topics: Administration, Oral; Atorvastatin; Chemotherapy, Adjuvant; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Exudates and Transudates; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Laser Coagulation; Lipoproteins, LDL; Macular Edema; Male; Middle Aged; Prospective Studies; Pyrroles; Triglycerides; Visual Acuity | 2004 |
Effectiveness of ketorolac tromethamine 0.5% ophthalmic solution for chronic aphakic and pseudophakic cystoid macular edema.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aphakia, Postcataract; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Humans; Ketorolac Tromethamine; Lenses, Intraocular; Macular Edema; Ophthalmic Solutions; Pyrroles; Random Allocation; Time Factors; Tolmetin; Tromethamine; Visual Acuity | 1987 |
3 other study(ies) available for pyrroles and Macular Edema
| Article | Year |
|---|---|
Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis.
Topics: Administration, Oral; Arthritis, Juvenile; Female; Humans; Janus Kinase Inhibitors; Macula Lutea; Macular Edema; Piperidines; Pyrimidines; Pyrroles; Tomography, Optical Coherence; Uveitis, Anterior; Visual Acuity; Young Adult | 2019 |
Cytotoxicity considerations and electrically tunable release of dexamethasone from polypyrrole for the treatment of back-of-the-eye conditions.
Topics: Cell Line; Cell Survival; Delayed-Action Preparations; Dexamethasone; Drug Delivery Systems; Drug Liberation; Electrochemistry; Humans; Macular Degeneration; Macular Edema; Polymerization; Polymers; Pyrroles | 2016 |
Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas.
Topics: Adult; Angiogenesis Inhibitors; Female; Fluorescein Angiography; Hemangioblastoma; Humans; Indoles; Infusions, Intravenous; Macular Edema; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Retinal Neoplasms; Visual Acuity; von Hippel-Lindau Disease | 2003 |